Studies on toluene diisocyanate (TDI)-induced delayed type hypersensitivity

Area of Science:

• Immunology
• Toxicology
• Pharmacology

Background:

• Delayed type hypersensitivity (DTH) reactions are critical immune responses.
• Toluene diisocyanate (TDI) is an industrial chemical known to cause respiratory sensitization.
• Understanding TDI's immunomodulatory effects is crucial for occupational health.

Purpose of the Study:

• To investigate and characterize the toluene diisocyanate (TDI)-induced delayed type hypersensitivity (DTH) reaction in mice.
• To compare the TDI-induced DTH model with the established picryl chloride (PC)-induced DTH model.
• To evaluate the utility of the TDI-induced DTH model for drug efficacy assessment.

Main Methods:

• Induction of DTH in male ICR mice using various concentrations of TDI.
• Comparison of ear swelling response between TDI and PC sensitization.
• Assessment of vasopermeability using Evans' blue dye leakage.
• Evaluation of anti-inflammatory drugs, dexamethasone (DX) and indomethacin (IM), on TDI-induced DTH.

Main Results:

• TDI induced a significant DTH reaction in mice, comparable or stronger than PC.
• Age and mouse strain influenced DTH reactivity, with younger mice and specific strains (ICR, BALB/c) showing higher responses.
• Ear swelling correlated positively with Evans' blue dye leakage, indicating increased vasopermeability.
• Dexamethasone and indomethacin significantly suppressed the TDI-induced DTH reaction, with dexamethasone showing greater efficacy.

Conclusions:

• The TDI-induced DTH mouse model is a viable and sensitive system for studying DTH reactions.
• This model, incorporating dye leakage as a measure of vasopermeability, can be effectively used for evaluating drugs aimed at treating DTH-related disorders.
• The findings highlight TDI's potent immunogenic properties and provide a platform for further research into hypersensitivity mechanisms and treatments.